193 related articles for article (PubMed ID: 2098548)
41. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum.
Ryu JM; Chung SJ; Lee MH; Kim CK; ShimCK
J Control Release; 1999 May; 59(2):163-72. PubMed ID: 10332051
[TBL] [Abstract][Full Text] [Related]
42. In vitro release of meclozine hydrochloride from lipophilic suppository bases with or without tensides.
Bećirević M; Petricić V; Kallay N
Pharmazie; 1984 Dec; 39(12):828-30. PubMed ID: 6531391
[TBL] [Abstract][Full Text] [Related]
43. The enhancing mechanism of capric acid (C10) from a suppository on rectal drug absorption through a paracellular pathway.
Takahashi H; Shibasaki T; Takeshita K; Kaiho F; Hayashi M
Biol Pharm Bull; 1997 Apr; 20(4):446-8. PubMed ID: 9145228
[TBL] [Abstract][Full Text] [Related]
44. Rectal bioavailability of amoxicillin sodium in rabbits: Effects of suppository base and drug dose.
Purohit TJ; Hanning SM; Amirapu S; Wu Z
J Control Release; 2021 Oct; 338():858-869. PubMed ID: 34534590
[TBL] [Abstract][Full Text] [Related]
45. Enhanced rectal absorption of sodium ampicillin by N-acyl derivatives of collagen peptide in rabbits and rats.
Yata N; Wu WM; Yamajo R; Murakami T; Higashi Y; Higuchi T
J Pharm Sci; 1985 Oct; 74(10):1058-61. PubMed ID: 4078702
[TBL] [Abstract][Full Text] [Related]
46. Enhancement of rectal absorption of insulin using salicylates in dogs.
Nishihata T; Rytting JH; Kamada A; Higuchi T; Routh M; Caldwell L
J Pharm Pharmacol; 1983 Mar; 35(3):148-51. PubMed ID: 6132970
[TBL] [Abstract][Full Text] [Related]
47. [Experiences with the rectal use of chemotherapeutic agents. 2. Pharmacokinetic examinations with animals].
Sallai J; Vernyik A; Erös I; Regdon G; Gombkötö Z; Németh J; Regdon G
Acta Pharm Hung; 1998 Jul; 68(4):229-33. PubMed ID: 9737024
[TBL] [Abstract][Full Text] [Related]
48. Rectal absorption of ozagrel from a suppository containing its commercial tablet in healthy human subjects.
Zheng NX; Sato H; Kobayashi F; Masuko Y; Adachi I; Horikoshi I
Biol Pharm Bull; 1997 Mar; 20(3):282-4. PubMed ID: 9084888
[TBL] [Abstract][Full Text] [Related]
49. Rectal Administration of Celecoxib Liquid Suppositories with Enhanced Bioavailability and Safety in Rats.
Jiao Y; Xie S; Baseer A; Ud-Din F
Curr Drug Deliv; 2023; 20(2):201-210. PubMed ID: 35570559
[TBL] [Abstract][Full Text] [Related]
50. Effect of adjuvants on the rectal absorption and lymphatic uptake of pepleomycin in rats.
Nishihata T; Yasui K; Yamazaki M; Kamada A
J Pharmacobiodyn; 1984 May; 7(5):278-85. PubMed ID: 6206221
[TBL] [Abstract][Full Text] [Related]
51. [Effect of pharmaceutical adjuvants on the rectal permeability of drugs. I. Effect of pharmaceutical additives on the permeability of sulfaguanidine from the rat rectum].
Nakanishi K; Miyazaki S; Masada M; Nadai T
Yakugaku Zasshi; 1982 Dec; 102(12):1133-40. PubMed ID: 7182448
[No Abstract] [Full Text] [Related]
52. Improved systemic delivery of insulin by condensed drug loading in a dimpled suppository.
Matsumoto A; Murakami K; Watanabe C; Murakami M
Drug Discov Ther; 2017; 11(6):293-299. PubMed ID: 29332886
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of mucin as a release enhancer for rectal delivery of glibenclamide.
Adikwu MU; Okafor JO
Curr Drug Deliv; 2006 Jul; 3(3):243-54. PubMed ID: 16848726
[TBL] [Abstract][Full Text] [Related]
54. Rectal absorption of omeprazole from suppository in humans.
Choi MS; Chung SJ; Shim CK
J Pharm Sci; 1996 Aug; 85(8):893-4. PubMed ID: 8863285
[TBL] [Abstract][Full Text] [Related]
55. Enhanced rectal absorption of theophylline, lidocaine, cefmetazole, and levodopa by several adjuvants.
Nishihata T; Rytting JH; Higuchi T
J Pharm Sci; 1982 Aug; 71(8):865-8. PubMed ID: 6956716
[TBL] [Abstract][Full Text] [Related]
56. Study of the mechanism behind adjuvant action of diethylethoxymethylene malonate enhancing the rectal absorption of cefmetazole and lysozyme.
Nishihata T; Miyake M; Kamada A
J Pharmacobiodyn; 1984 Sep; 7(9):607-13. PubMed ID: 6597309
[TBL] [Abstract][Full Text] [Related]
57. Development of a thermo-reversible insulin liquid suppository with bioavailability enhancement.
Yun M; Choi H; Jung J; Kim C
Int J Pharm; 1999 Nov; 189(2):137-45. PubMed ID: 10536242
[TBL] [Abstract][Full Text] [Related]
58. Rectal absorption of [Bis (acetato) ammine dichloro (cyclohexylamine) platinum(IV)] (BMS-182751), a new anti-tumor agent, in rats.
Tanaka M; Kuwahara E; Shimizu T; Chikazawa H; Hisada S; Takahashi N
Biol Pharm Bull; 1999 May; 22(5):521-6. PubMed ID: 10375175
[TBL] [Abstract][Full Text] [Related]
59. Relative bioavailability and plasma paracetamol profiles of Panadol suppositories in children.
Coulthard KP; Nielson HW; Schroder M; Covino A; Matthews NT; Murray RS; Van Der Walt JH
J Paediatr Child Health; 1998 Oct; 34(5):425-31. PubMed ID: 9767504
[TBL] [Abstract][Full Text] [Related]
60. Prolonged release of morphine alkaloid from a lipophilic suppository base in vitro and in vivo.
Morgan DJ; McCormick Y; Cosolo W; Roller L; Zalcberg J
Int J Clin Pharmacol Ther Toxicol; 1992 Dec; 30(12):576-81. PubMed ID: 1473873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
